Yeah the key for cellular therapies coupled with manufacturing and FDA approval (initial + ongoing re: approval mode) is the IP in the array matrix, which Si is clearly reiterating was effectively in place for MSB-GVHD0001, clarification of which has now been accepted by FDA. Should turn the real scientists back on in my ignore list at this critical juncture but...nah, easter Sunday's no time for religious zealots.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-480
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.13 |
Change
0.050(4.65%) |
Mkt cap ! $1.284B |
Open | High | Low | Value | Volume |
$1.08 | $1.13 | $1.07 | $5.964M | 5.444M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | $1.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.13 | 176236 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 1.110 |
2 | 149752 | 1.100 |
1 | 16932 | 1.095 |
1 | 16932 | 1.090 |
1 | 16932 | 1.085 |
Price($) | Vol. | No. |
---|---|---|
1.130 | 176236 | 7 |
1.135 | 72500 | 2 |
1.140 | 41258 | 4 |
1.145 | 14746 | 2 |
1.150 | 18885 | 5 |
Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.12 |
  |
Change
0.050 ( 4.69 %) |
|||
Open | High | Low | Volume | ||
$1.09 | $1.13 | $1.07 | 829227 | ||
Last updated 15.59pm 21/05/2024 ? |
Featured News
MSB (ASX) Chart |
The Watchlist
AUQ
ALARA RESOURCES LIMITED
Stephen Gethin, Non-Executive Director & Chairman
Stephen Gethin
Non-Executive Director & Chairman
Previous Video
Next Video
SPONSORED BY The Market Online